Engineering a mevalonate pathway in Escherichia coli for production of terpenoids

被引:0
|
作者
Vincent J J Martin
Douglas J Pitera
Sydnor T Withers
Jack D Newman
Jay D Keasling
机构
[1] 201 Gilman Hall,Department of Chemical Engineering
[2] University of California,undefined
[3] Lawrence Berkeley National Laboratory,undefined
来源
Nature Biotechnology | 2003年 / 21卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Isoprenoids are the most numerous and structurally diverse family of natural products. Terpenoids, a class of isoprenoids often isolated from plants, are used as commercial flavor and fragrance compounds and antimalarial or anticancer drugs. Because plant tissue extractions typically yield low terpenoid concentrations, we sought an alternative method to produce high-value terpenoid compounds, such as the antimalarial drug artemisinin, in a microbial host. We engineered the expression of a synthetic amorpha-4,11-diene synthase gene and the mevalonate isoprenoid pathway from Saccharomyces cerevisiae in Escherichia coli. Concentrations of amorphadiene, the sesquiterpene olefin precursor to artemisinin, reached 24 μg caryophyllene equivalent/ml. Because isopentenyl and dimethylallyl pyrophosphates are the universal precursors to all isoprenoids, the strains developed in this study can serve as platform hosts for the production of any terpenoid compound for which a terpene synthase gene is available.
引用
收藏
页码:796 / 802
页数:6
相关论文
共 50 条
  • [21] Production of γ-aminobutyric acid in Escherichia coli by engineering MSG pathway
    Yu, Ping
    Chen, Kaifei
    Huang, Xingxing
    Wang, Xinxin
    Ren, Qian
    PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY, 2018, 48 (10): : 906 - 913
  • [22] Production of mevalonate by a metabolically-engineered Escherichia coli
    Tabata, K
    Hashimoto, SI
    BIOTECHNOLOGY LETTERS, 2004, 26 (19) : 1487 - 1491
  • [23] Production of mevalonate by a metabolically-engineered Escherichia coli
    Kazuhiko Tabata
    Shin-Ichi Hashimoto
    Biotechnology Letters, 2004, 26 : 1487 - 1491
  • [24] Isoprene production by Escherichia coli through the exogenous mevalonate pathway with reduced formation of fermentation byproducts
    Kim, Jung-Hun
    Wang, Chonglong
    Jang, Hui-Jung
    Cha, Myeong-Seok
    Park, Ju-Eon
    Jo, Seon-Yeong
    Choi, Eui-Sung
    Kim, Seon-Won
    MICROBIAL CELL FACTORIES, 2016, 15
  • [25] Isoprene production by Escherichia coli through the exogenous mevalonate pathway with reduced formation of fermentation byproducts
    Jung-Hun Kim
    Chonglong Wang
    Hui-Jung Jang
    Myeong-Seok Cha
    Ju-Eon Park
    Seon-Yeong Jo
    Eui-Sung Choi
    Seon-Won Kim
    Microbial Cell Factories, 15
  • [26] Engineering Escherichia coli for production of functionalized terpenoids using plant P450s
    Chang, Michelle C. Y.
    Eachus, Rachel A.
    Trieu, William
    Ro, Dae-Kyun
    Keasling, Jay D.
    NATURE CHEMICAL BIOLOGY, 2007, 3 (05) : 274 - 277
  • [27] Engineering Escherichia coli for production of functionalized terpenoids using plant P450s
    Michelle C Y Chang
    Rachel A Eachus
    William Trieu
    Dae-Kyun Ro
    Jay D Keasling
    Nature Chemical Biology, 2007, 3 : 274 - 277
  • [28] Engineering the lactococcal mevalonate pathway for increased sesquiterpene production
    Song, Adelene A.
    Ong Abdullah, Janna
    Abdullah, Mohd. P.
    Shafee, Norazizah
    Othman, Roohaida
    Noor, Normah Mohd
    Rahim, Raha A.
    FEMS MICROBIOLOGY LETTERS, 2014, 355 (02) : 177 - 184
  • [29] Metabolic engineering of a xylose pathway for biotechnological production of glycolate in Escherichia coli
    Liu, Min
    Ding, Yamei
    Xian, Mo
    Zhao, Guang
    MICROBIAL CELL FACTORIES, 2018, 17
  • [30] Genomic engineering of Escherichia coli for production of intermediate metabolites in the aromatic pathway
    Chen, Po Ting
    Chiang, Chung-Jen
    Wang, Jen-You
    Lee, Ming-Zei
    Chao, Yun-Peng
    JOURNAL OF THE TAIWAN INSTITUTE OF CHEMICAL ENGINEERS, 2011, 42 (01) : 34 - 40